Pay in 4 interest-free payments of $5.67 Learn more
Ships within 48 hours · Estimated delivery Sep 27 - Oct 2
Pain and Physical Function Improvements TRIUMPH-4's co-primary endpoint focused on knee osteoarthritis pain, measured by the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) pain subscale: WOMAC Pain Score Reductions: Retatrutide 9mg: -4.5 points (75.8% reduction) Retatrutide 12mg: -4.4 points (73.3% reduction) Placebo: -2.4 points (40.3% reduction) Participants also experienced substantial improvements in physical function, with WOMAC physical function subscale scores improving by: Retatrutide 9mg: -4.1 points Retatrutide 12mg: -4.2 points Placebo: -2.1 points Perhaps most remarkably, a post-hoc analysis revealed that 14.1% of participants on 9mg and 12.0% on 12mg became completely pain-free at 68 weeks, compared to just 4.2% on placebo
Explore us Global US UK CHINA Japan Hongkong Korea Turkey Ireland IE Austria Belgium Czech Republic Denmark Finland France Germany View All Countries English EN Account Welcome Sign in Create an Account Your Orders Track Order Your Wishlist 0 Added to Cart Hongkong Hongkong Switching between stores will remove products from your current cart
How fast will I see results with Strive tirzepatide
However, its essential to discuss these options with your healthcare provider to determine the best course of action based on your personal health needs and goals
